Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.

Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D' Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V.

Haematologica. 2019 Oct 3. pii: haematol.2019.228171. doi: 10.3324/haematol.2019.228171. [Epub ahead of print]

2.

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.

Della Starza I, Cavalli M, De Novi LA, Genuardi E, Mantoan B, Drandi D, Barbero D, Ciabatti E, Grassi S, Gazzola A, Mannu C, Agostinelli C, Piccaluga PP, Bomben R, Degan M, Gattei V, Guarini A, Foà R, Galimberti S, Ladetto M, Ferrero S, Del Giudice I; Fondazione Italiana Linfomi (FIL) MRD Network.

Hematol Oncol. 2019 Jul 19. doi: 10.1002/hon.2652. [Epub ahead of print]

PMID:
31325190
3.

Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial Cells.

Agostinis C, Masat E, Bossi F, Ricci G, Menegazzi R, Lombardelli L, Zito G, Mangogna A, Degan M, Gattei V, Piccinni MP, Kishore U, Bulla R.

Int J Mol Sci. 2019 Mar 31;20(7). pii: E1604. doi: 10.3390/ijms20071604.

4.

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines.

D'Agaro T, Zucchetto A, Vit F, Bittolo T, Tissino E, Rossi FM, Degan M, Zaja F, Bulian P, Bo MD, Ferrero S, Ladetto M, Zamò A, Gattei V, Bomben R.

Haematologica. 2019 Sep;104(9):e410-e414. doi: 10.3324/haematol.2018.212811. Epub 2019 Feb 28. No abstract available.

5.

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs.

Minuz P, Meneguzzi A, Fumagalli L, Degan M, Calabria S, Ferraro R, Ricci M, Veneri D, Berton G.

Front Pharmacol. 2018 Sep 26;9:1081. doi: 10.3389/fphar.2018.01081. eCollection 2018.

6.

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

Bulian P, Bomben R, Bo MD, Zucchetto A, Rossi FM, Degan M, Pozzo F, Bittolo T, Bravin V, D'Agaro T, Cerri M, Chiarenza A, Chaffee KG, Condoluci A, D'Arena G, Spina M, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Poeta GD, Gaidano G, Shanafelt TD, Gattei V.

Haematologica. 2017 Nov;102(11):e443-e446. doi: 10.3324/haematol.2017.170340. Epub 2017 Jul 27. No abstract available.

7.

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

D'Agaro T, Bittolo T, Bravin V, Dal Bo M, Pozzo F, Bulian P, Rossi FM, Zucchetto A, Degan M, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Gaidano G, Del Poeta G, Gattei V, Bomben R.

Br J Haematol. 2018 Aug;182(4):597-602. doi: 10.1111/bjh.14843. Epub 2017 Jul 12. No abstract available.

PMID:
28699643
8.

Mutations in the 3' untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia.

Bittolo T, Pozzo F, Bomben R, D'Agaro T, Bravin V, Bulian P, Rossi FM, Zucchetto A, Degan M, Macor P, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Gaidano G, Del Poeta G, Gattei V, Dal Bo M.

Haematologica. 2017 Aug;102(8):e305-e309. doi: 10.3324/haematol.2016.162594. Epub 2017 May 26. No abstract available.

9.

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.

Pozzo F, Bittolo T, Vendramini E, Bomben R, Bulian P, Rossi FM, Zucchetto A, Tissino E, Degan M, D'Arena G, Di Raimondo F, Zaja F, Pozzato G, Rossi D, Gaidano G, Del Poeta G, Gattei V, Dal Bo M.

Leukemia. 2017 Nov;31(11):2407-2415. doi: 10.1038/leu.2017.90. Epub 2017 Mar 21.

PMID:
28321119
10.

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles.

Giacomazzi A, Degan M, Calabria S, Meneguzzi A, Minuz P.

Front Pharmacol. 2016 Sep 16;7:314. eCollection 2016.

11.

A Skyline Plugin for Pathway-Centric Data Browsing.

Degan MG, Ryadinskiy L, Fujimoto GM, Wilkins CS, Lichti CF, Payne SH.

J Am Soc Mass Spectrom. 2016 Nov;27(11):1752-1757. Epub 2016 Aug 16.

PMID:
27530777
12.

CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

Dal Bo M, Bulian P, Bomben R, Zucchetto A, Rossi FM, Pozzo F, Tissino E, Benedetti D, Bittolo T, Nanni P, Cattarossi I, Zaina E, Chivilò H, Degan M, Zaja F, Pozzato G, Chiarenza A, Di Raimondo F, Del Principe MI, Del Poeta G, Rossi D, Gaidano G, Gattei V.

Leukemia. 2016 Oct;30(10):2011-2018. doi: 10.1038/leu.2016.88. Epub 2016 Apr 25.

PMID:
27109509
13.

The Pacific Northwest National Laboratory library of bacterial and archaeal proteomic biodiversity.

Payne SH, Monroe ME, Overall CC, Kiebel GR, Degan M, Gibbons BC, Fujimoto GM, Purvine SO, Adkins JN, Lipton MS, Smith RD.

Sci Data. 2015 Aug 18;2:150041. doi: 10.1038/sdata.2015.41. eCollection 2015.

14.

A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.

Treggiari D, Zoccatelli G, Molesini B, Degan M, Rotino GL, Sala T, Cavallini C, MacRae CA, Minuz P, Pandolfini T.

Mol Nutr Food Res. 2015 Nov;59(11):2255-66. doi: 10.1002/mnfr.201500267. Epub 2015 Aug 26.

PMID:
26255647
15.

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Pozzo F, Bittolo T, Arruga F, Bulian P, Macor P, Tissino E, Gizdic B, Rossi FM, Bomben R, Zucchetto A, Benedetti D, Degan M, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Rossi D, Gaidano G, Del Poeta G, Deaglio S, Gattei V, Dal Bo M.

Leukemia. 2016 Jan;30(1):182-9. doi: 10.1038/leu.2015.182. Epub 2015 Jul 13.

PMID:
26165233
16.

Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial.

Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P.

Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):861-8. doi: 10.1016/j.numecd.2014.02.015. Epub 2014 Mar 5.

PMID:
24787908
17.

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

Pozzo F, Dal Bo M, Peragine N, Bomben R, Zucchetto A, Rossi F, Degan M, Rossi D, Chiarenza A, Grossi A, Di Raimondo F, Zaja F, Pozzato G, Secchiero P, Gaidano G, Del Poeta G, Zauli G, Fo À R, Guarini A, Gattei V.

J Hematol Oncol. 2013 Nov 5;6:83. doi: 10.1186/1756-8722-6-83.

18.

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A, Rossi FM, Monti S, Degan M, Ciardullo C, Serra R, Zucchetto A, Nomdedeu J, Bulian P, Grossi A, Zaja F, Pozzato G, Laurenti L, Efremov DG, Di-Raimondo F, Marasca R, Forconi F, Del Poeta G, Gaidano G, Gattei V.

Blood. 2013 Jun 13;121(24):4902-5. doi: 10.1182/blood-2013-02-486209. Epub 2013 May 1.

PMID:
23637131
19.

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.

Dal Bo M, Pozzo F, Bomben R, Degan M, Marconi D, Zucchetto A, Rossi D, Pozzato G, Zauli G, Gaidano G, Del Poeta G, Gattei V.

Br J Haematol. 2013 May;161(4):596-9. doi: 10.1111/bjh.12258. Epub 2013 Feb 14. No abstract available.

PMID:
23406297
20.

Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.

Del Poeta G, Dal Bo M, Del Principe MI, Pozzo F, Rossi FM, Zucchetto A, Bomben R, Degan M, Rasi S, Rossi D, Bulian P, Gaidano G, Amadori S, Gattei V.

Br J Haematol. 2013 Feb;160(3):415-8. doi: 10.1111/bjh.12128. Epub 2012 Nov 20. No abstract available.

PMID:
23167503
21.

Endothelial dysfunction and increased oxidative stress in mitochondrial diseases.

Minuz P, Fava C, Vattemi G, Arcaro G, Riccadonna M, Tonin P, Meneguzzi A, Degan M, Guglielmi V, Lechi A, Tomelleri G.

Clin Sci (Lond). 2012 Mar;122(6):289-97. doi: 10.1042/CS20110199.

PMID:
21970465
22.

Anti-angiogenic effects of two cystine-knot miniproteins from tomato fruit.

Cavallini C, Trettene M, Degan M, Delva P, Molesini B, Minuz P, Pandolfini T.

Br J Pharmacol. 2011 Mar;162(6):1261-73. doi: 10.1111/j.1476-5381.2010.01154.x.

23.

Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement.

Vattemi G, Mechref Y, Marini M, Tonin P, Minuz P, Grigoli L, Guglielmi V, Klouckova I, Chiamulera C, Meneguzzi A, Di Chio M, Tedesco V, Lovato L, Degan M, Arcaro G, Lechi A, Novotny MV, Tomelleri G.

Mol Cell Proteomics. 2011 Apr;10(4):M110.002964. doi: 10.1074/mcp.M110.002964. Epub 2010 Dec 14.

24.

MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3.

Bo MD, Secchiero P, Degan M, Marconi D, Bomben R, Pozzato G, Gaidano G, Del Poeta G, Forconi F, Zauli G, Gattei V.

Br J Haematol. 2010 Jul;150(2):237-9. doi: 10.1111/j.1365-2141.2010.08185.x. Epub 2010 Apr 28. No abstract available.

PMID:
20507307
25.

Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.

Rossi FM, Del Principe MI, Rossi D, Irno Consalvo M, Luciano F, Zucchetto A, Bulian P, Bomben R, Dal Bo M, Fangazio M, Benedetti D, Degan M, Gaidano G, Del Poeta G, Gattei V.

J Transl Med. 2010 Mar 8;8:23. doi: 10.1186/1479-5876-8-23.

26.

Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.

Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.

Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12.

27.

IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia.

Bomben R, Dal Bo M, Capello D, Forconi F, Bertoni F, Maffei R, Laurenti L, Rossi D, Zucca E, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.

Br J Haematol. 2010 Apr;149(2):299-302. doi: 10.1111/j.1365-2141.2009.08046.x. Epub 2009 Jan 7. No abstract available.

PMID:
20064162
28.

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.

Cancer Res. 2009 May 1;69(9):4001-9. doi: 10.1158/0008-5472.CAN-08-4173. Epub 2009 Apr 21.

29.

Endothelial progenitor cells in patients with severe peripheral arterial disease.

Delva P, De Marchi S, Prior M, Degan M, Lechi A, Trettene M, Arosio E.

Endothelium. 2008 Sep-Oct;15(5-6):246-53. doi: 10.1080/10623320802487718.

PMID:
19065316
30.

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.

Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V.

Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19.

PMID:
19036101
31.

[Analysis of the educational requirements and planning in a large public hospital].

Degan M, Bragato L, Duminuco L, Bagno C, Genova V, Sansoni J.

Prof Inferm. 2007 Oct-Dec;60(4):195-206. Italian.

PMID:
18289491
32.

Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.

Lorenzon D, Mazzucato M, Abbruzzese L, Cilli M, De Angeli S, Degan M, Mambrini G, Piccardi F, Rupolo M, Michieli M, De Marco L, Gattei V, Astori G.

Vox Sang. 2008 May;94(4):342-50. doi: 10.1111/j.1423-0410.2008.01038.x. Epub 2008 Feb 14.

PMID:
18282263
33.

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

Del Poeta G, Del Principe MI, Buccisano F, Maurillo L, Capelli G, Luciano F, Perrotti AP, Degan M, Venditti A, de Fabritiis P, Gattei V, Amadori S.

Cancer. 2008 Jan 1;112(1):119-28.

34.

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal-Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G.

Blood. 2008 Jan 15;111(2):865-73. Epub 2007 Oct 24.

PMID:
17959854
35.

Inflammation and platelet activation in peripheral arterial occlusive disease.

Montagnana M, Fava C, Arosio E, Degan M, Tommasoli RM, De Marchi S, Delva P, Spadaro R, Guidi GC, Lechi A, Santonastaso CL, Minuz P.

Int J Angiol. 2007 Fall;16(3):84-8.

36.

Transcriptional regulation of anthocyanin biosynthesis in ripening fruits of grapevine under seasonal water deficit.

Castellarin SD, Pfeiffer A, Sivilotti P, Degan M, Peterlunger E, DI Gaspero G.

Plant Cell Environ. 2007 Nov;30(11):1381-99.

37.

Iloprost infusion does not reduce oxidative stress in systemic sclerosis.

Volpe A, Biasi D, Caramaschi P, Bambara LM, Carletto A, Degan M, Minuz P.

Rheumatol Int. 2008 Feb;28(4):335-7. Epub 2007 Aug 18.

PMID:
17704920
38.

Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10.

Benedetti D, Bomben R, Dal-Bo M, Marconi D, Zucchetto A, Degan M, Forconi F, Del-Poeta G, Gaidano G, Gattei V.

Leukemia. 2008 Jan;22(1):224-6. Epub 2007 Jul 26. No abstract available.

PMID:
17657217
39.

Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.

Spessotto P, Zucchetto A, Degan M, Wasserman B, Danussi C, Bomben R, Perris R, Canzonieri V, Radillo O, Colombatti A, Gattei V.

Matrix Biol. 2007 Jul;26(6):473-84. Epub 2007 Apr 11.

PMID:
17482449
40.

Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.

Terrin L, Trentin L, Degan M, Corradini I, Bertorelle R, Carli P, Maschio N, Bo MD, Noventa F, Gattei V, Semenzato G, De Rossi A.

Leukemia. 2007 May;21(5):965-72. Epub 2007 Mar 8.

PMID:
17344921
41.

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.

Bomben R, Dal Bo M, Capello D, Benedetti D, Marconi D, Zucchetto A, Forconi F, Maffei R, Ghia EM, Laurenti L, Bulian P, Del Principe MI, Palermo G, Thorsélius M, Degan M, Campanini R, Guarini A, Del Poeta G, Rosenquist R, Efremov DG, Marasca R, Foà R, Gaidano G, Gattei V.

Blood. 2007 Apr 1;109(7):2989-98.

PMID:
17148579
42.

Endothelial progenitor cells in patients with essential hypertension.

Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G, Di Chio M, Lechi A.

J Hypertens. 2007 Jan;25(1):127-32.

PMID:
17143183
43.

Insulin and glucose mediate opposite intracellular ionized magnesium variations in human lymphocytes.

Delva P, Degan M, Trettene M, Lechi A.

J Endocrinol. 2006 Sep;190(3):711-8.

PMID:
17003272
44.

ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.

Zucchetto A, Bomben R, Bo MD, Nanni P, Bulian P, Rossi FM, Del Principe MI, Santini S, Del Poeta G, Degan M, Gattei V.

Cytometry B Clin Cytom. 2006 Jul 15;70(4):284-92.

45.

Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.

Minuz P, Fumagalli L, Gaino S, Tommasoli RM, Degan M, Cavallini C, Lecchi A, Cattaneo M, Lechi Santonastaso C, Berton G.

Biochem J. 2006 Nov 15;400(1):127-34.

46.

Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates.

Lippi G, Montagnana M, Salvagno GL, Cicorella N, Degan M, Minuz P, Lechi C, Guidi GC.

Int J Cardiol. 2007 Jan 31;115(1):101-2. Epub 2006 Jul 3. No abstract available.

PMID:
16820229
47.

Oxidized low density lipoprotein (LDL) and platelet intracellular calcium: interaction with nitric oxide.

Zuliani V, Tommasol R, Gaino S, Degan M, Cominacini L, Davoli A, Lechi C, Lechi A, Minuz P.

Platelets. 1998;9(3-4):269-72.

PMID:
16793716
48.

Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: evidence of simultaneous expansion of two independent clones.

Gottardi M, Gattei V, Degan M, Bomben R, Zucchetto A, Tecchio C, Laurino L, Zanatta L, Dei Tos AP, Mordacchini M, Canal F, Gherlinzoni F.

Leuk Lymphoma. 2006 May;47(5):885-9.

PMID:
16753874
49.

Evaluation of platelet turnover by flow cytometry.

Salvagno GL, Montagnana M, Degan M, Marradi PL, Ricetti MM, Riolfi P, Poli G, Minuz P, Santonastaso CL, Guidi GC.

Platelets. 2006 May;17(3):170-7.

PMID:
16702044
50.

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.

Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S.

Blood. 2006 Aug 1;108(3):853-61. Epub 2006 Apr 6.

PMID:
16601244

Supplemental Content

Support Center